MYOSTEATOSIS IN METASTATIC GYNECOLOGIC CANCER: CURRENT STATE OF THE PROBLEM

SHAKHANOVA Shakhnoza Shavkatovna, KHOSHIMOV Bakhodir Bakhromovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2026-yil

Annotatsiya

Myosteatosis, defined as fatty infiltration of skeletal muscle, is an important component of body composition disorders in oncology. In metastatic gynecologic cancers, this condition is frequently underestimated when relying on conventional anthropometric measures, despite its significant impact on treatment tolerance and prognosis. This review summarizes current evidence on the pathophysiological mechanisms of myosteatosis, its association with chemotherapy-related toxicity, and its influence on overall and progression-free survival. Computed tomography–derived muscle density is shown to be an independent prognostic factor of adverse oncologic outcomes, particularly in patients with preserved or increased body mass index. The integration of myosteatosis assessment into multifactorial risk stratification models may improve personalized management strategies for patients with metastatic gynecologic malignancies.

Maqola ma’lumotlari
MualliflarSHAKHANOVA Shakhnoza Shavkatovna, KHOSHIMOV Bakhodir Bakhromovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2026-05-06
Jild11
Son2
TilRus

Kalit so‘zlar

миостеатоз, онкогинекологический рак, метастазы, токсичность химиотерапии, выживаемость, компьютерная томография, myosteatosis, gynecologic cancer, metastasis, chemotherapy toxicity, survival, computed tomography, miosteatoz, onkoginekologik rak, metastazlar, kimyoterapiya toksikligi, omon qolish, kompyuter tomografiya

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar